/viestories/media/media_files/2025/05/16/nS7EJD06HrUEIcPSFxyu.png)
Natco Pharma Share Price Target: We aim to give investors a unique idea. Before investing in any stock, especially during times of huge ups and downs in market volatility. It's important to understand the research and take advice from experts to show the company’s growth and performance.
Natco Pharma Share Price Target is actively traded in the share market. In this article, we will cover the company’s financial growth, business strategies, shareholding patterns, and yearly share price forecasts. Let's see the Natco Pharma share price target from 2025, 2026 to 2030, 2035, 2040, 2045, to 2050.
Table of Contents
- Natco Pharma Limited Share Price Chart
- Fundamental Analysis Of Natco Pharma Limited
- Natco Pharma share price Target 2025
- Natco Pharma share price Target 2026
- Natco Pharma share price Target 2027
- Natco Pharma share price Target 2028
- Natco Pharma share price Target 2029
- Natco Pharma share price Target 2030
- Natco Pharma share price Target 2050
- Conclusion - Natco Pharma Share Price
Natco Pharma Limited Share Price Chart
Natco Pharma Limited Share Price last 5 years. Its grown from around RS 500 to RS 1500 with lots of ups and down, you can see the chart.
Fundamental Analysis Of Natco Pharma Limited
Company Name |
Natco Pharma Limited |
Market Cap |
₹26,215.98 Crore |
P/B |
4.5 |
Face Value |
₹2 |
Book Value |
₹347.98 |
52 Week High |
₹1,540.12 |
52 Week Low |
₹724.20 |
DIV. YIELD |
0.67% |
Natco Pharma share price Target 2025
Month (2025) |
Maximum Target |
MinimumTarget |
January |
1110 |
1420 |
February |
757 |
1341 |
March |
708 |
1350 |
April |
656 |
1368 |
May |
600 |
1358 |
June |
678 |
1369 |
July |
780 |
1380 |
August |
874 |
1400 |
September |
988 |
1425 |
October |
1125 |
1458 |
November |
1258 |
1511 |
December |
1358 |
1618 |
Natco Pharma share price Target 2026
Month (2050) |
Maximum Target |
MinimumTarget |
January |
1618 |
1945 |
February |
1354 |
1548 |
March |
1125 |
1287 |
April |
964 |
1121 |
May |
1059 |
1254 |
June |
1144 |
1548 |
July |
1354 |
1641 |
August |
1484 |
1745 |
September |
1669 |
2044 |
October |
1941 |
2241 |
November |
2145 |
2357 |
December |
2290 |
2473 |
Natco Pharma share price Target 2027
Month (2027) |
Maximum Target |
MinimumTarget |
January |
2290 |
2490 |
February |
1842 |
2041 |
March |
1524 |
1754 |
April |
1647 |
1982 |
May |
1785 |
2154 |
June |
1954 |
2265 |
July |
2145 |
2351 |
August |
2274 |
2474 |
September |
2365 |
2584 |
October |
2458 |
2754 |
November |
2578 |
2954 |
December |
2854 |
3039 |
Natco Pharma share price Target 2028
Month (2028) |
Maximum Target |
MinimumTarget |
January |
2854 |
3080 |
February |
2954 |
3145 |
March |
3021 |
3178 |
April |
3125 |
3225 |
May |
3187 |
3268 |
June |
3242 |
3365 |
July |
3347 |
3378 |
August |
3354 |
3458 |
September |
3390 |
3494 |
October |
3452 |
3545 |
November |
3490 |
3690 |
December |
3587 |
3727 |
Natco Pharma share price Target 2029
Month (2029) |
Maximum Target |
MinimumTarget |
January |
3587 |
3787 |
February |
3645 |
3821 |
March |
3754 |
3856 |
April |
3784 |
3887 |
May |
3826 |
3925 |
June |
3878 |
4021 |
July |
3954 |
4087 |
August |
4053 |
4121 |
September |
4078 |
4156 |
October |
4120 |
4225 |
November |
4156 |
4280 |
December |
4243 |
4357 |
Natco Pharma share price Target 2030
Month (2030) |
Maximum Target |
MinimumTarget |
January |
4243 |
4390 |
February |
3841 |
4025 |
March |
3652 |
3755 |
April |
3512 |
3858 |
May |
3756 |
3954 |
June |
3867 |
4051 |
July |
3957 |
4151 |
August |
4057 |
4284 |
September |
4157 |
4358 |
October |
4254 |
4658 |
November |
4547 |
4984 |
December |
4851 |
5055 |
Natco Pharma share price Target 2050
Month (2050) |
Maximum Target |
MinimumTarget |
January |
15000 |
15325 |
February |
15241 |
15458 |
March |
15354 |
15684 |
April |
15451 |
15841 |
May |
15754 |
16241 |
June |
16058 |
16354 |
July |
16154 |
16548 |
August |
16254 |
16684 |
September |
16441 |
16784 |
October |
16574 |
16924 |
November |
16844 |
17254 |
December |
17121 |
17457 |
Conclusion - Natco Pharma Share Price
The company has a good chance for growth in the future, with its share price likely to rise in the future, thanks to its strong business performance in countries such as the U.S. and Brazil. The company is financially stable, with low debt, healthy profits, and continuous dividend payments. However, the stock has been unstable due to its weaker earnings, which is not a good investment for a short period.
Explore more -
Disclaimer
This blog is for educational purposes only and is not financial advice. Before making any decision to invest, investors should research or take advice from a financial advisor.
- The information is based on our understanding of the stock's historical performance.
- Stock market predictions are unpredictable and can change, so expert advice is strongly recommended before investing.
- The values provided are based on predictions and may not be accurate, we recommend verifying the information with other sources.
- For further inquiries about the stock market, please contact us via email.